Form D · Pharmaceuticals
WinSanTor
San Diego, CA · CIK 0001611161
Offering snapshot reported Nov 16, 2017 · SEC filing
- Reported sold
- $783K Offering amount: $2M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- May 10, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2017 | Initial | $782,939 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-298937
Source: Form D, filed Nov 16, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nigel Calcutt | Director |
| Stan Kim | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9255 Towne Centre Dr. #930
San Diego, CA, 92121
San Diego, CA, 92121